Tetraphase Pharmaceutical (TTPH:NAS) and Aptevo Therapeutics (APVO:NAS) Trading at Less than Cash Value

Stockcalc – Free Trial

Have a free look inside the StockCalc website at www.stockcalc.com



I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/TopPicks.aspx.

Trading at Less than Cash Value

Today we are looking at companies trading at less than cash value meaning companies whose current share price is less than the cash per share on the balance sheet. We also show the value of cash net debt per share to show how much cash per share would be left if the debt was paid off.

What this Means…

Companies can have more cash per share than the actual share price for a number of reasons including they just raised capital, are in industries that experience high burn rates and will eat through the cash quickly or if there is a lot of uncertainty about the future of the company. Companies earning a positive net income will have a P/E greater than 0 and are worth exploring in more detail.

Today’s Data on NASDAQ

Today’s data is for companies listed on the NASDAQ.

Symbol Name Close Price Shares Outstanding P/E P/B Cash per Share Net Cash per Share
LEXEB Liberty Expedia Holdings Inc 49.440800 57274157 1.3014 1.0854 51.70 -33.28
LEXEA Liberty Expedia Holdings Inc 38.490000 57274157 1.0045 0.8450 51.70 -33.28
PDLI PDL BioPharma Inc 2.470000 154338793 4.9400 0.4632 3.30 1.75
AXON Axovant Sciences Ltd 1.680000 107788074 None 1.6980 1.75 1.26
FWP Forward Pharma A/S 3.150000 47183999 2.4803 0.1266 28.75 0.96
TTPH Tetraphase Pharmaceuticals Inc 2.120000 51414631 None 0.7298 3.14 4.00
OPHT Ophthotech Corp 2.860000 36038683 1.8101 2.3492 5.00 5.84
APVO Aptevo Therapeutics Inc 3.290000 21428468 None 0.7806 3.54 2.72
AGTC Applied Genetic Technologies Corp 3.750000 18104901 None 0.6085 3.89 0.44
VSAR Versartis Inc 1.700000 35809311 None 1.2363 3.32 3.17
CCUR CCUR Holdings Inc 5.420000 9880038 None 0.8621 5.82 3.17
CYTR CytRx Corp 1.540000 27637634 None 1.9820 1.66 1.26
APWC Asia Pacific Wire & Cable Corp Ltd 2.615000 13819669 7.6912 0.2449 3.54 0.44
GIGM GigaMedia Ltd 2.840000 11052235 None 0.5225 5.77 5.77
TNXP Tonix Pharmaceuticals Holding Corp 3.310000 7830040 None 0.9037 3.74 0.23
IPIC IPic Entertainment Inc 11.110000 12385629 None None 314.50 -14829.16
VXRT Vaxart Inc 6.557600 3513563 None 2.1334 8.37 8.28
VLRX Valeritas Holdings Inc 3.150000 7132782 None 2.2704 4.78 -0.13
CYCC Cyclacel Pharmaceuticals Inc 1.600000 11904521 None 0.8120 2.19 0.97
ABAC Renmin Tianli Group Inc 2.150000 7983745 19.5455 0.1939 7.56 7.30
CREG China Recycling Energy Corp 2.030000 8310198 None 0.0799 5.81 -0.21
KBSF KBS Fashion Group Ltd 5.330000 1771132 None 0.1170 13.17 11.87
ZSAN Zosano Pharma Corp 4.295000 1973046 None 0.5954 6.74 2.59
DCIX Diana Containerships Inc 2.780000 757193 None 0.0163 10.80 -26.46
HUNT Hunter Maritime Acquisition Corp 9.820000 4312500 None None 35.37 None

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

TTPH:NAS Tetraphase Pharmaceutical

http://www.tphase.com
Tetraphase Pharmaceutical has 66 employees and is headquartered in United States.
Tetraphase Pharmaceuticals Inc is a clinical stage biopharmaceutical company engaged in creating novel antibiotics for serious and life-threatening multidrug-resistant infections.

APVO:NAS Aptevo Therapeutics

http://www.aptevotherapeutics.com
Aptevo Therapeutics has 118 employees and is headquartered in United States.
Aptevo Therapeutics Inc is a biosciences company. The Company is engaged in the discovery, development, commercialization and sale of novel oncology and hematology therapeutics.

Free Valuation

Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.